Silo Pharma, Inc.
SILO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001514183
No open-market purchases or sales by Silo Pharma, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $886.6K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Silo Pharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −3 vs. Q4 2024
- Shares held
- 248.4K
- +57.7K (+30.2%) vs. Q4 2024
- Total value
- $285.0K
- +$116.6K (+69.2%) vs. Q4 2024
- New holders
- 4
- 2 more added
- Sold out
- 7
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SILO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $886.6K |
| Q1 2026 | 15 | $379.8K |
| Q4 2025 | 15 | $412.4K |
| Q3 2025 | 14 | $1.07M |
| Q2 2025 | 13 | $256.3K |
| Q1 2025 | 13 | $285.0K |
| Q4 2024 | 16 | $168.4K |
| Q3 2024 | 13 | $383.3K |
| Q2 2024 | 10 | $117.9K |
| Q1 2024 | 11 | $1.22M |
| Q4 2023 | 10 | $231.3K |
| Q3 2023 | 8 | $175.7K |
| Q2 2023 | 7 | $203.6K |
| Q1 2023 | 6 | $183.3K |
| Q4 2022 | 8 | $72.3K |
| Q3 2022 | 4 | $273.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Silo Pharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 124,236 | $140.4K | 0.03% | +124,236 | New |
| Geode Capital Management, LLC | 44,487 | $52.0K | 0.00% | +9,539+27.3% | Added |
| Citadel Advisors LLC | 20,689 | $24.2K | 0.00% | +20,689 | New |
| Conning Inc. | 20,000 | $23.4K | 0.00% | +20,000 | New |
| Vanguard Group Inc | 16,334 | $19.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 12,500 | $14.6K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 6,000 | $7.02K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,532 | $1.79K | 0.00% | −1,159−43.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,454 | $1.70K | 0.00% | −3,093−68.0% | Reduced |
| Advisor Group Holdings, Inc. | 500 | $585 | 0.00% | +500 | New |
| Westside Investment Management, Inc. | 94 | $110 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 38 | $44 | 0.00% | +2+5.6% | Added |
| Lazard Asset Management LLC | 570 | $0 | 0.00% | −383−40.2% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −20,085−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,563−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,375−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,448−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,430−100.0% | Sold out |
| Bullock Wealth Management Group | 0 | $0 | 0.00% | −7,246−100.0% | Sold out |